Targeted delivery of CX3CL1 to multiple lung tumors by mesenchymal stem cells

Stem Cells

Volumn 25, Issue 7, 2007, Pages 1618-1626

  Xin, Hong ^a   Kanehira, Masahiko ^a,b   Mizuguchi, Hiroyuki ^c   Hayakawa, Takao ^d   Kikuchi, Toshiaki ^b   Nukiwa, Toshihiro ^b   Saijo, Yasuo ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOHOKU UNIVERSITY   (Japan)

^c NATIONAL INSTITUTE OF BIOMEDICAL INNOVATION   (Japan)

^d PHARMACEUTICALS AND MEDICAL DEVICES AGENCY   (Japan)

Author keywords

Gene therapy; Lung metastases; Mesenchymal stem cell; Multiple tumors

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID 4C; CHEMOKINE; FRACTALKINE; GREEN FLUORESCENT PROTEIN; PEPTIDE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANALYTIC METHOD; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER SURVIVAL; CELL GROWTH; CONTROLLED STUDY; INNATE IMMUNITY; LUNG METASTASIS; LUNG TUMOR; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; TUMOR CELL;

3T3 CELLS; ADENOVIRIDAE; ANIMALS; BETA-GALACTOSIDASE; CD8-POSITIVE T-LYMPHOCYTES; CELL DIFFERENTIATION; CHEMOKINES, CX3C; FEMALE; GENE THERAPY; GENETIC VECTORS; KILLER CELLS, NATURAL; LUNG NEOPLASMS; MEMBRANE PROTEINS; MESENCHYMAL STEM CELLS; MICE; NEOPLASM METASTASIS; OLIGOPEPTIDES; ORGAN SPECIFICITY; TRANSDUCTION, GENETIC; TROPISM;

MUS;

EID: 34547167177     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1634/stemcells.2006-0461     Document Type: Article

References (36)

1. Tahara H, Lotze MT, Robbins PD et al. IL-12 gene therapy using direct injection of tumors with genetically engineered autologous fibroblasts. Hum Gene Ther 1995;6:1607-1624.
2. Iwaguro H, Yamaguchi J, Kalka C et al. Endothelial progenitor cell vascular endothelial growth factor gene transfer for vascular regeneration. Circulation 2002;105:732-738.
3. Specht JM, Wang G, Do MT et al. Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J Exp Med 1997;186:1213-1221.
4. Rosenberg SA, Yannelli JR, Yang JC et al. Treatment of patients with metastatic melanoma with autologous tumor-infiltrating lymphocytes and interleukin-2. J Natl Cancer Inst 1994;86:1159-1166.
5. Kasid A, Morecki S, Aebersold P et al. Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man. Proc Natl Acad Sci USA 1990;87:473-477.
6. Rosenberg SA, Aebersold P, Cornetta K et al. Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction. N Engl J Med 1990;323:570-578.
7. Colter DC, Class R, DiGirolamo CM et al. J Rapid expansion of recycling stem cells in cultures of plastic-adherent cells from human bone marrow. Proc Natl Acad Sci USA 2000;97:3213-3218.
8. Pittenger MF, Mackay AM, Beck SC et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284:143-147.
9. Gojo S, Gojo N, Takeda Y et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res 2003;288:51-59.
10. Sato Y, Araki H, Kato J et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood 2005;5;106:756-763.
11. Rojas M, Xu J, Woods CR et al. Bone marrow-derived mesenchymal stem cells in repair of the injured lung. Am J Respir Cell Mol Biol 2005;33:145-152.
12. Hung SC, Deng WP, Yang WK et al. Mesenchymal stem cell targeting of microscopic tumors and tumor stroma development monitored by noninvasive in vivo positron emission tomography imaging. Clin Cancer Res 2005;11:7749-7756.
13. Studeny M, Marini FC, Champlin RE et al. Bone marrow-derived mesenchymal stem cells as vehicles for interferon-beta delivery into tumors. Cancer Res 2002;62:3603-3608.
14. Studeny M, Marini FC, Dembinski JL et al. Mesenchymal stem cells: Potential precursors for tumor stroma and targeted-delivery vehicles for anticancer agents. J Natl Cancer Inst 2004;96:1593-1603.
15. Nakamizo A, Marini F, Amano T et al. Human bone marrow-derived mesenchymal stem cells in the treatment of gliomas. Cancer Res 2005;65:3307-3318.
16. Pereboeva L, Komarova S, Mikheeva G et al. Approaches to utilize mesenchymal progenitor cells as cellular vehicles. STEM CELLS 2003;21:389-404.
17. Tsuda H, Wada T, Ito Y et al. Efficient BMP2 gene transfer and bone formation of mesenchymal stem cells by a fiber-mutant adenoviral vector. Mol Ther 2003;7:354-365.
18. Bazan JF, Bacon KB, Hardiman G et al. A new class of membrane-bound chemokine with a CX3C motif. Nature 1997;385:640-644.
19. Rossi D, Zlotnik A. The biology of chemokines and their receptors. Annu Rev Immunol 2000;18:217-242.
20. Imai T, Hieshima K, Haskell C et al. Identification and molecular characterization of fractalkine receptor CX3CR1, which mediates both leukocyte migration and adhesion. Cell 1997;91:521-530.
21. Xin H, Kikuchi T, Andarini S et al. Antitumor immune response by CX3CL1 fractalkine gene transfer depends on both NK and T cells. Eur J Immunol 2005;35:1371-1380.
22. Arai F, Ohneda O, Miyamoto T et al. Mesenchymal stem cells in perichondrium express activated leukocyte cell adhesion molecule and participate in bone marrow formation. J Exp Med 2002;195:1549-1563.
23. Mizuguchi H, Koizumi N, Hosono T et al. A simplified system for constructing recombinant adenoviral vectors containing heterologous peptides in the HI loop of their fiber knob. Gene Ther 2001;8:730-735.
24. Gao JQ, Tsuda Y, Katayama K et al. Antitumor effect by interleukin-11 receptor alpha-locus chemokine/CCL27, introduced into tumor cells through a recombinant adenovirus vector. Cancer Res 2003;63:4420-4425.
25. Wynn RF, Hart CA, Corradi-Perini C et al. A small proportion of mesenchymal stem cells strongly expresses functionally active CXCR4 receptor capable of promoting migration to bone marrow. Blood 2004;104:2643-2645.
26. Sordi V, Malosio ML, Marchesi F et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005;106:419-427.
27. Son BR, Marquez-Curtis LA, Kucia M et al. Migration of bone marrow and cord blood mesenchymal stem cells in vitro is regulated by SDF-1-CXCR4 and HGF-c-met axes and involves matrix metalloproteinases. STEM CELLS 2006;24:1254-1264.
28. Mangi AA, Noiseux N, Kong D et al. Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts. Nat Med 2003;9:1195-1201.
29. Hung SC, Lu CY, Shyue SK et al. Lineage differentiation-associated loss of adenoviral susceptibility and coxsackie-adenovirus receptor expression in human mesenchymal stem cells. STEM CELLS 2004;22:1321-1329.
30. Peister A, Mellad JA, Larson BL et al. Adult stem cells from bone marrow (MSCs) isolated from different strains if inbred mice vary in surface epitopes, rates of proliferation, and differentiation potential. Blood 2004;103:1662-1668.
31. Aboody KS, Brown A, Rainov NG et al. Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas. Proc Natl Acad Sci USA 2000;97:12846-12851.
32. Benedetti S, Pirola B, Pollo B et al. Gene therapy of experimental brain tumors using neural progenitor cells. Nat Med 2000;6:447-450.
33. Brown AB, Yang W, Schmidt NO et al. Intravascular delivery of neural stem cell lines to target intracranial and extracranial tumors of neural and non-neural origin. Hum Gene Ther 2003;14:1777-1785.
34. Lee J, Elkahloun AG, Messina SA et al. Cellular and genetic characterization of human adult bone marrow-derived neural stem-like cells: A potential antiglioma cellular vector. Cancer Res 2003;63:8877-889.
35. Pevsner-Fischer M, Morad V, Cohen-Sfady M et al. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 2007;109:1422-1432.
36. Phinney DG, Kopen G, Isaacson RL et al. Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: Variations in yield, growth, and differentiation. J Cell Biochem 1999;72:570-585.